Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2 results

Filters applied: . Clear all
The following terms were not found in PubMed: monophosphate+Endothelial, permeability+Nitric, oxide+Phospholipase
Page 1
Interaction of PKC and NOS in signal transduction of microvascular hyperpermeability.
Huang Q, Yuan Y. Huang Q, et al. Am J Physiol. 1997 Nov;273(5):H2442-51. doi: 10.1152/ajpheart.1997.273.5.H2442. Am J Physiol. 1997. PMID: 9374783
Our previous studies have shown that inflammatory mediators increase microvascular permeability through a phospholipase C-nitric oxide synthase (NOS)-guanylate cyclase cascade. The aim of this study is to delineate in more detail the signaling pathway leading …
Our previous studies have shown that inflammatory mediators increase microvascular permeability through a phospholipase C-nitric
Myosin light chain phosphorylation: modulation of basal and agonist-stimulated venular permeability.
Yuan Y, Huang Q, Wu HM. Yuan Y, et al. Am J Physiol. 1997 Mar;272(3 Pt 2):H1437-43. doi: 10.1152/ajpheart.1997.272.3.H1437. Am J Physiol. 1997. PMID: 9087622
We have previously demonstrated that agonists increase microvascular permeability through a phospholipase C-nitric oxide synthase-guanylate cyclase cascade. The aim of this study was to further investigate the downstream end of the signaling pathway with a fo …
We have previously demonstrated that agonists increase microvascular permeability through a phospholipase C-nitric oxide